Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zabedosertib - Bayer

Next Previous
Search
Drug Profile

Zabedosertib - Bayer

Alternative Names: BAY 1834845; IRAK-4 inhibitor - Bayer

Latest Information Update: 28 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer
  • Class Amides; Anti-inflammatories; Antipsoriatics; Antirheumatics; Fluorinated hydrocarbons; Indazoles; Organic sulfur compounds; Pyridines; Skin disorder therapies; Small molecules
  • Mechanism of Action IRAK4 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Atopic dermatitis
  • No development reported Pelvic inflammatory disorders; Psoriasis; Rheumatoid arthritis; Unspecified

Most Recent Events

  • 28 Jul 2024 No recent reports of development identified for phase-I development in Unspecified(In volunteers) in Netherlands (PO, Tablet)
  • 03 Jan 2024 Bayer completes phase-II Damask trial in Atopic dermatitis (In adults, In the elderly) in United Kingdom, Italy, Poland, Germany, France, Czech Republic and USA (PO) (NCT05656911)
  • 28 Aug 2023 No recent reports of development identified for phase-I development in Psoriasis in Germany (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top